(Lisdexamfetamine Dimesylate)
Vyvanse is currently listed on the FDA drug shortage list (since July 2023). Medfinder's availability score is 5% (Very Difficult to Find), based on 21,595 pharmacy checks in the last 30 days. 3,499 patients have searched for Vyvanse in the last 30 days. Last updated 4/28/2026.
Generated by Medfinder AI using proprietary data alongside publicly available data from the FDA and other sources.
Availability Score
Percentage of Medfinder pharmacy checks over the last 30 days that found this drug in stock. Calculated as in-stock reports ÷ total reports.5%(Very Difficult to Find)
FDA Status
Critical ShortageWe've helped 907 patients find Vyvanse in stock over the last month.
Patient Shortage Reports
3,499
Total Pharmacies Checked
21,595
In Stock Percentage
5%
Total patient shortage reports for this medication over the last 8 weeks.
| Dosage | Total Pharmacies Checked | Change | Last Located | In Stock Percentage |
|---|---|---|---|---|
Get access to real-time availability data by region, pharmacy, and dosage — updated daily from thousands of pharmacy checks.
Summarized by Medfinder AI
FDA Status
Critical ShortageStart Date
07/14/2023
Get a weekly email with the latest drug shortage updates, resolutions, and availability changes.
![Who Has Vyvanse in Stock Near You? Find It Today [2026]](/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2Fvur4atr4%2Fproduction%2F1079f61f167dcbc2ed5f1da17a0dcb0b7166357e-1024x1024.png%3Frect%3D0%2C256%2C1024%2C512%26w%3D400%26h%3D200%26auto%3Dformat&w=828&q=75)
We have a 99% success rate finding medications, even during nationwide shortages. Let us do the searching for you.
